CRISPR Therapeutics Stock Quote CRSP - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

52.47

Bid

52.40

Ask

52.49

Volume

946,133

52.0301 Day's Range 54.5472

43.42 52 Week Range 91.10

Market Cap

4.478B

Previous Close

55.15

Open

54.17

Last Trade

52.49

Last Trade Time

13:06:16

Financial Volume

$ 49,897,399

VWAP

52.7383

Average Volume (3m)

1,403,690

Shares Outstanding

85,353,479

Dividend Yield

PE Ratio

-29.13

Earnings Per Share (EPS)

-1.8

Revenue

371.21M

Net Profit

-153.61M

CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specifi... CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.crisprtx.com

Headquarters

Zug, Che

Founded

CRISPR Therapeutics AG is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CRSP. The last closing price for CRISPR Therapeutics was $55.15. Over the last year, CRISPR Therapeutics shares have traded in a share price range of $ 43.42 to $ 91.10.

CRISPR Therapeutics currently has 85,353,479 shares outstanding. The market capitalization of CRISPR Therapeutics is $4.71 billion. CRISPR Therapeutics has a price to earnings ratio (PE ratio) of -29.13.

Overall Flow

Bearish

Net Premium

-2M

Calls / Puts

60.00%

Buys / Sells

50.00%

OTM / ITM

33.33%

Sweeps Ratio

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	2.47	4.94	50	55.5	48.49	1653836	52.98360832	CS
4	3.25	6.60300690776	49.22	59.0693	45.51	1975107	50.0682484	CS
12	7.47	16.6	45	59.0693	44.14	1403690	48.80279582	CS
26	-2.41	-4.39139941691	54.88	67.88	43.42	1335189	51.73154712	CS
52	-16.63	-24.0665701881	69.1	91.1	43.42	1664127	60.54310591	CS
156	-24.38	-31.724137931	76.85	91.1	37.55	1502050	59.8831062	CS
260	-15.42	-22.7132125497	67.89	220.21	32	1427848	78.66440499	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CTNTCheetah Net Supply Chain Service Inc	$ 5.75 (207.49%)	107.18M
ZJKZJK Industrial Company Ltd	$ 15.22 (140.06%)	19.39M
JYDJayud Global Logistics Ltd	$ 1.185 (76.84%)	5.87M
GWAVGreenwave Technology Solutions Inc	$ 0.5812 (59.23%)	350.59M
JANXJanux Therapeutics Inc	$ 62.055 (54.44%)	5.46M
REVBRevelation Biosciences Inc	$ 0.56 (-41.05%)	3.52M
STSSSharps Technology Inc	$ 2.2386 (-33.25%)	299.79k
GELSGelteq Ltd	$ 2.6136 (-31.59%)	235.13k
OMEXOdyssey Marine Exploration Inc	$ 0.51 (-31.56%)	3.36M
SGBXSafe and Green Holdings Corporation	$ 0.4944 (-27.72%)	3.13M
GWAVGreenwave Technology Solutions Inc	$ 0.5812 (59.23%)	350.59M
SMCISuper Micro Computer Inc	$ 41.51 (-1.17%)	161.22M
CTNTCheetah Net Supply Chain Service Inc	$ 5.75 (207.49%)	107.18M
CHRSCoherus BioSciences Inc	$ 2.0177 (47.28%)	101.01M
CTORCitius Oncology Inc	$ 1.4408 (41.25%)	97.02M